Patents Review · Apr 2026
Patent coverage on cannabis haploid-detection methods suggests ongoing patent activity around breeding and ploidy-identification workflows at Rev Genomics.
Rev is a biotechnology company creating better plants.
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Oakland-based plant biotechnology company developing and licensing high-value crop cultivars using whole-genome selection, tissue culture, molecular genetics, and in-house metabolite analytics; public materials emphasize cannabis/high-value crop breeding and cultivar/IP licensing.
Primary product
Novel high-value crop cultivars plus a genomic breeding platform for cultivar development and licensing
Founded
2015
Headquarters
Oakland, California, United States
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Plant biotechnology / agricultural biotechnology
Offices
0 jobs at Rev Genomics
Check back later for new openings
Business model
Stage
Seed
Total raised
$1.6M
Latest round
Seed · May 2019
Latest amount
$1.5M
May 2019
Aug 2017 · Y Combinator
Founders
Co-Founder, VP Genomics
Investors
Small, research-heavy startup culture with a strong plant-science orientation. Public hiring copy suggests a fast pace, teamwork, flexibility, attention to detail, and a hands-on lab/research environment.
Compensation
Public compensation signals are limited. A YC job post advertised competitive salary, stock options, and a health-care plan; third-party salary pages estimate average pay around $110k/year, but there are no official salary bands publicly posted.
Benefits
Pricing
B2B licensing plus services
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M
Patents Review · Apr 2026
Patent coverage on cannabis haploid-detection methods suggests ongoing patent activity around breeding and ploidy-identification workflows at Rev Genomics.
Patents Review · Feb 2025
Covers a Rev Genomics patent application for stabilizing ploidy in cannabis/plant breeding, including self-fertilization and chromosome-doubling methods.
Patents Review · Feb 2024
Describes marker-assisted breeding claims in cannabis plants, reinforcing Rev Genomics' focus on genomic selection for cultivar development.
Nanalyze · Mar 2019
Profiles Rev Genomics as a Y Combinator-backed cannabis biotech startup using DNA/RNA sequencing and cell culture to improve breeding efficiency.
TechCrunch · Aug 2017
Introduces Rev Genomics as a cannabis genomics company aiming to improve yields and resistance through biotechnology and genomic selection.